Curiteva Achieves Over 1,000 Procedures With Innovative Inspire Cervical System

Curiteva, Inc., a privately held manufacturing and technology company, has announced that over 1,000 patients have been treated with the new 3D printed Inspire Cervical Trabecular PEEK Interbody Fusion System. This has resulted in more than 2,000 Inspire implants being placed in patients. The Inspire Cervical System was initially launched in April 2023 and fully commercialized by July.

Dr. Randy Dryer, Curiteva’s Medical Director, remarked, "I am seeing CT scans of patients at their three-month follow-up showing bone bridging from endplate to endplate through the porous structure of the device. This is unprecedented in my 40 years of practice." He added that while other companies have promoted porous PEEK implants, Curiteva's Trabecular PEEK is forming bone across the entire implant.

The Inspire platform is produced using a proprietary, patented Fused Filament Fabrication 3D printer designed and built by Curiteva. This advanced additive process creates a fully interconnected porous structure throughout the implant to promote osseointegration, enhance radiographic assessment, and provide superior biomechanics.

The combination of HAFUSE nanotechnology surface treatment and the novel porous PEEK structure establishes a hydrophilic, bioactive environment conducive to cell attachment, proliferation, and healing. This has been demonstrated in pre-clinical animal and in vitro studies.

Chad Falciani, Founder and Chairman of the Board for Curiteva, expressed pride in reaching this milestone. "Surpassing 1,000 procedures and over 2,000 implants within a year of commercialization is a testament to our team’s consistent effort and focus," he said. Falciani also mentioned that next month will see the expansion of Inspire Technology into lumbar applications, adding momentum to their growth.

About Curiteva

Curiteva is based in Huntsville, AL, and focuses on world-class manufacturing, accelerating research and development, maintaining lean operational discipline, and delivering new technology to meet the evolving needs of customers and patients. The company is pioneering 3D printing of Trabecular PEEK implants with a bioactive nano-surface to improve patient outcomes.

For more information about Curiteva and its products, visit www.curiteva.com.